Degenerative joint disease | Symptoms, Risk Groups & Treatment Options

 Home > Drugs > Degenerative joint disease

Degenerative joint disease

Osteoarthritis is a chronic joint disease characterized by local articular cartilage degeneration, bone loss, bone spur formation at the joint margins, joint deformity and subchondral bone density. It is also known as osteoarthritis, degenerative osteoarthritis, hyperplastic arthritis and senile arthritis. It is more common in people over 50 years old, more common in women than in men, and affects the quality of life of middle-aged and elderly patients to varying degrees.

Site of disease:

joint
Infectious :

Not contagious
Frequent population:

All groups
Related symptoms:

Joint swelling and pain Hip pain Shoulder pain Ankle pain Jaw joint pain
Concurrent disease:

Hemochromatosis osteoarthritis Hyperplastic osteoarthritis Pine caterpillar disease osteoarthritis Hypertrophic osteoarthritis Dialysis osteoarthritis

Related Drugs

Meloxicam Tablets

Indication: Indicated for symptomatic treatment of rheumatoid arthritis, painful osteoarthritis (arthrosis, degenerative osteoarthritis)

Manufacturer:

Yangtze River Pharmaceutical (Group) Co., Ltd.

Meloxicam Tablets

Indication: Indicated for the symptomatic treatment of rheumatoid arthritis and symptomatic treatment of painful osteoarthritis (arthrosis, degenerative osteoarthritis).

Manufacturer:

Sichuan Sunnyhope Pharmaceutical Co., Ltd.

Meloxicam Tablets

Indication: Indicated for the symptomatic treatment of rheumatoid arthritis and symptomatic treatment of painful osteoarthritis (arthrosis, degenerative osteoarthritis).

Manufacturer:

Tongfang Pharmaceutical Group Co., Ltd.

Compound Psoralea corylifolia Granules

Manufacturer:

Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.

Meloxicam Capsules